MELANOSOME PROTEIN SORTING, FOLDING & ANTIGEN PROCESSING
MELANOSOME PROTEIN SORTING, FOLDING & ANTIGEN PROCESSING
批准号:
2669586
负责人:
Michael S Marks
金额:
$21.96万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-07-01 至 2003-06-30
关键词:
CD4 molecule CD8 molecule HeLa cells MHC class I antigen MHC class II antigen T lymphocyte affinity chromatography antigen presentation chemical binding chimeric proteins crosslink endoplasmic reticulum fluorescence microscopy glycoproteins immunoelectron microscopy melanocyte melanosomes membrane proteins molecular shape monophenol monooxygenase neoplastic cell culture for noncancer research protein binding protein folding protein transport western blottings
中文摘要
酪氨酸酶和gp100在黑色素的生物合成中起作用
英文摘要
Tyrosinase and gp100 function in melanin biosynthesis and are resident
integral membrane proteins of a tissue-specific, lysosome-like organelle
called the melanosome. Failure of melanocytes to properly sort
tyrosinase or gp100 to the melanosome results in developmental and
pigment defects such as oculocutaneous albinism. Melanosomal sorting
may also affect immune responses to melanoma; tyrosinase and gp100 are
among the few human tumor-associated antigens recognized by CD4+, major
histocompatibility complex (MHC) class II-restricted T cells. The
mechanisms by which these proteins are sorted to melanosomes and the
relationship between melanosomal and MHC class II antigen sorting
pathways are poorly understood. We hypothesize that these two pathways
utilize similar intracellular sorting mechanisms and that proper sorting
is necessary for MHC class II-dependent antigen presentation. In
addition, tyrosinase is retained within the endoplasmic reticulum (ER)
and degraded by the proteasome under certain developmental conditions.
Proteasomal degradation may enhance antigen presentation by MHC class
I molecules. We hypothesize that tissue-specific activities regulate
the folding and/or assembly of tyrosinase and affect antigen processing
in melanic and non-melanic cells. The Specific Aims are: 1. To
identify melanosomal sorting determinants within tyrosinase and gp100.
Transfected cells will be analyzed morphologically for localization of
full-length molecules with targeted mutations or of chimeric proteins
containing isolated topologic domains derived from tyrosinase and gp100.
Cellular proteins that interact with identified determinants will be
characterized biochemically. 2. To characterize the determinants of
tyrosinase retention within the endoplasmic reticulum of non-melanic
cells. Cell type differences between melanic and non-melanic cells in
the ER protein folding environment and in the assembly and stoichiometry
of tyrosinase and chimeric proteins containing isolated tyrosinase
topologic domains will be determined using biochemical and genetic
criteria. 3. To determine whether sorting and folding affect tyrosinase
(and gp100) recognition by CD4+ and CD8+ T lymphocytes, respectively.
Melanosomal proteins will be colocalized with MHC molecules in melanoma
and transfected non-melanic cells. The effect of altering the protein
sorting and/or retention properties of tyrosinase and gp100 on
recognition by specific T cell clones will be determined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic and molecular basis for variation in human skin pigmentation
-
批准号:10394237
-
项目类别:
-
资助金额:$109.91万
-
财政年份:2020
-
负责人:Michael S Marks
-
依托单位:
Genetic and molecular basis for variation in human skin pigmentation
-
批准号:10615919
-
项目类别:
-
资助金额:$111.02万
-
财政年份:2020
-
负责人:Michael S Marks
-
依托单位:
Mechanisms regulating ion transport across the melanosomal membrane in health and disease
-
批准号:9763909
-
项目类别:
-
资助金额:$6.66万
-
财政年份:2019
-
负责人:Michael S Marks
-
依托单位:
Mechanisms regulating ion transport across the melanosomal membrane in health and disease
-
批准号:10401826
-
项目类别:
-
资助金额:$36.68万
-
财政年份:2018
-
负责人:Michael S Marks
-
依托单位:
Mechanisms regulating ion transport across the melanosomal membrane in health and disease
-
批准号:10400351
-
项目类别:
-
资助金额:$5.76万
-
财政年份:2018
-
负责人:Michael S Marks
-
依托单位:
Mechanisms regulating ion transport across the melanosomal membrane in health and disease
-
批准号:10164721
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2018
-
负责人:Michael S Marks
-
依托单位:
Platelet granule formation and function in health and disease
-
批准号:9055752
-
项目类别:
-
资助金额:$48.16万
-
财政年份:2014
-
负责人:Michael S Marks
-
依托单位:
Platelet granule formation and function in health and disease
-
批准号:8703361
-
项目类别:
-
资助金额:$50.4万
-
财政年份:2014
-
负责人:Michael S Marks
-
依托单位:
Platelet granule formation and function in health and disease
-
批准号:8846666
-
项目类别:
-
资助金额:$48.58万
-
财政年份:2014
-
负责人:Michael S Marks
-
依托单位:
Platelet granule formation and function in health and disease
-
批准号:9257459
-
项目类别:
-
资助金额:$47.56万
-
财政年份:2014
-
负责人:Michael S Marks
-
依托单位:
2012 and 2014 Lysosomes & Endocytosis Gordon Research Conference
-
批准号:8252386
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2012
-
负责人:Michael S Marks
-
依托单位:
Disease-related defects in dendritic cell processing of bacterial antigens
-
批准号:8190963
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2011
-
负责人:Michael S Marks
-
依托单位:
Disease-related defects in dendritic cell processing of bacterial antigens
-
批准号:8266319
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2011
-
负责人:Michael S Marks
-
依托单位:
Platelet granule biogenesis in health and disease
-
批准号:7893963
-
项目类别:
-
资助金额:$19.97万
-
财政年份:2010
-
负责人:Michael S Marks
-
依托单位:
Platelet granule biogenesis in health and disease
-
批准号:8069579
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2010
-
负责人:Michael S Marks
-
依托单位:
Iron and copper transporter trafficking in healthy and diseased melanocytes
-
批准号:7282640
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2006
-
负责人:Michael S Marks
-
依托单位:
Iron and copper transporter trafficking in healthy and diseased melanocytes
-
批准号:7136169
-
项目类别:
-
资助金额:$13.35万
-
财政年份:2006
-
负责人:Michael S Marks
-
依托单位:
Hermansky Pudlak Syndrome & melanosome formation
-
批准号:8117490
-
项目类别:
-
资助金额:$50.35万
-
财政年份:2004
-
负责人:Michael S Marks
-
依托单位:
Hermansky Pudlak Syndrome & melanosome formation
-
批准号:6888018
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2004
-
负责人:Michael S Marks
-
依托单位:
Hermansky Pudlak syndrome and melanosome formation
-
批准号:10801554
-
项目类别:
-
资助金额:$9.3万
-
财政年份:2004
-
负责人:Michael S Marks
-
依托单位:
海外基金